Journals / Ağrı / 2019 / Cilt: 31 - Sayı: 4

Investigation of the risk factors for the transition of episodic migraines to chronic migraines

Kronik migrene dönüşüm üzerine etkili risk faktörlerinin araştırılması

Journal
Ağrı
Pages
172–177
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Based on the present data of a tertiary headache center, it was concluded that CM is a disabling neurological disease with a serious personal and public burden.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Chronic migraine (CM) is a frequent complication of migraines that has a serious impact on personal and social life and is still underdiagnosed.
📊
Key Findings & Data:Methods: In all, 115 CM and 377 episodic migraine patients from between February 2015 and December 2017 were enrolled.
💡
Conclusion & Impact:Conclusion: Based on the present data of a tertiary headache center, it was concluded that CM is a disabling neurological disease with a serious personal and public burden.
🔬Design:Research Article
📍Scope:2015 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: Chronic migraine (CM) is a frequent complication of migraines that has a serious impact on personal and social life and is still underdiagnosed. The aim of this study was to determine risk factors for the progression to CM and to investigate the relationship of these factors to the disease prognosis. Methods: In all, 115 CM and 377 episodic migraine patients from between February 2015 and December 2017 were enrolled. The age of disease onset, headache duration and frequency, presence of aura and type of aura, clinical properties and location of headache, pain severity, trigger factors, presence of family history, visual analogue scale (VAS) and Allodynia Symptom Checklist (ASC) scores, presence of allodynia, and Migraine Disability Assessment (MIDAS) scores were recorded and the 2 groups were compared statistically. Logistic regression was used to determine the independent risk factors for a conversion to CM. Results: The mean age of the 492 patients (408 female, 84 male) was 36.03±12.67 years, the disease duration was 10.78±10.36 years, the attack frequency was 10.35±9.06 attacks/month, and the attack duration was 30.10±23.54 hours. There were 115 patients (104 female, 11 male) with CM. Female gender (p=0.015), attack frequency (p<0.001), ASC score (p=0.002), VAS score (p=0.001), and MIDAS score (p<0.001) had greater representation in the CM group. Medication overuse (relative risk [RR]: 0.9) and allodynia (RR: 0.3) were independent risk factors for a transition to CM in the logistic regression analysis (p<0.05). Conclusion: Based on the present data of a tertiary headache center, it was concluded that CM is a disabling neurological disease with a serious personal and public burden. Special care should be taken among patients with medication overuse and cutaneous allodynia with regard to the possibility of transition to CM.

Özet

Amaç: Kronik migren (KM), toplumda sık rastlanan, ciddi sosyoekonomik ve kişisel engelliliğe yol açabilen fakat halen tanısal zorlukların yaşandığı bir migren komplikasyonudur. Bu çalışmada amacımız, üçüncü basamak bir başağrısı polikliniğine başvurmuş ve KM tanısı ile takip edilmekte olan hastalarda, kronik migrene dönüşümde etkili olabilecek faktörlerin belirlenmesi ve bu faktörlerin hastalık prognozuna olan etkilerini araştırmaktır. Gereç ve Yöntem: Baş Ağrısı Polikliniğimize, Şubat 2015–Aralık 2017 tarihleri arasında baş ağrısı yakınması ile başvuran hastalar arasından 115 KM ve 377 epizodik migren (EM) hastası çalışmaya dahil edilmiştir. Hastalık başlangıç yaşı, baş ağrısının süresi ve sıklığı, aura varlığı ve tipi, baş ağrısının klinik özellikleri ve lokalizasyonu, ağrının şiddeti, tetikleyici faktörler, aile öyküsü varlığı, VAS ve ASC skorları, allodini varlığı, MIDAS skorları kaydedilmiş ve iki grup istatistiksel olarak karşılaştırılmıştır. KM e dönüşümde bağımsız risk faktörlerinin belirlenebilmesi amacıyla lojistik regresyon yöntemi kullanılmıştır. Bulgular: 492 hastanın (408 kadın, 84 erkek) yaş ortalaması 36,03±12,67 yıl, hastalık süresi 10,78±10,36 yıl, atak sıklığı 10,35±9,06 atak/ay, atak süresi 30,10±23,54 saat idi. KM tanısı olan 115 hasta (104 kadın, 11 erkek) bulunmaktaydı. Kadın cinsiyet (p=0,015), atak sıklığı (p<0,001), ASC (p=0,002), VAS (p=0,001) ve MIDAS skorları (p<0,001) KM grubunda daha yüksekti. Lojistik regresyon analizinde, KM’e dönüşümde ilaç aşırı kullanımı (RR:0,9) ve allodini varlığı (RR:0,3) bağımsız risk faktörleri olarak bulundu (p<0,05). Sonuç: Üçüncü basamak bir merkezin verilerine dayanan çalışmamızın sonuçları, KM in gerek bireysel gerek toplumsal olarak ciddi engellilik oluşturabilen bir nörolojik hastalık olduğu, özellikle aşırı ilaç kullanımı ve kutanöz allodini tarifleyen hastalarda KM e dönüşüm açısından daha dikkatli olunması gerektiğini göstermektedir.

🔖

Cite This Article

ATALAR, A. Ç., YALIN, O. Ö. (2019). Investigation of the risk factors for the transition of episodic migraines to chronic migraines. Ağrı, Cilt: 31 - Sayı: 4, 172–177. https://ajindex.com/articles/212593

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Özge A, Uluduz D, Selekler M, Öztürk M, Baykan B, Çınar N, et al. Gender differences in older adults with chronic migraine in Turkey. Geriatr Gerontol Int 2015;15(5):652–8
  2. Buse DC, Manack AN, Fanning KM, Serrano D, Reed ML, Turkel CC, et al. Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study. Headache 2012;52(10):1456–70
  3. Blumenfeld AM, Varon SF, Wilcox TK, Buse DC, Kawata AK, Manack A, et al. Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS). Cephalalgia 2011;31(3):301–15
  4. Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB. Acute migraine medications and evolution from episodic to chronic migraine: A longitudinal population-based study. Headache 2008;48(8):1157–68
  5. Headache Classification Subcommittee of the International Headache Society (IHS). The International Classification of Headache Disorders: 3rd edition (beta version). Cephalalgia 2013;33:629–808
  6. Becker WJ. The Diagnosis and Management of Chronic Migraine in Primary Care. Headache 2017;57(9):1471–81
  7. May A, Schulte LH. Chronic migraine: risk factors, mechanisms and treatment. Nat Rev Neurol 2016;12(8):455–64
  8. Schulte LH, Allers A, May A. Hypothalamus as a mediator of chronic migraine: Evidence from high-resolution fMRI. Neurology 2017;88(21):2011–16
  9. Wewers ME, Lowe NK. A critical review of visual analogue scales in the measurement of clinical phenomena. Res Nurs Health 1990;13(4):227–36
  10. Heller GZ, Manuguerra M, Chow R. How to analyze the Visual Analogue Scale: Myths, truths and clinical relevance. Scand J Pain 2016;13:67–75
  11. Lipton RB, Bigal ME, Ashina S, Burstein R, Silberstein S, Reed ML, et al. Cutaneous allodynia in the migraine population. Ann Neurol 2008;63(2):148–58
  12. Yalın OÖ, Uludüz D, Sungur MA, Sart H, Özge A. Identification of Allodynic Migraine Patients with the Turkish Version of the Allodynia Symptom Checklist: Reliability and Consistency Study. Noro Psikiyatr Ars 2017;54(3):260–6
  13. Ekizoglu E, Baykan B, Orhan EK, Ertas M. The analysis of allodynia in patients with idiopathic intracranial hypertension. Cephalalgia 2012;32(14):1049–58
  14. Stewart WF, Lipton RB, Kolodner K, Liberman J, Sawyer J. Reliability of the migraine disability assessment score in a population-based sample of headache sufferers. Cephalalgia 1999;19(2):107–14
  15. Ertaş M, Siva A, Dalka